FSTL1 increases cisplatin sensitivity in epithelial ovarian cancer cells by inhibition of NF- κB pathway

ConclusionFSTL1 may inhibit NF- κB signaling pathway to suppress the growth and promote the apoptosis of epithelial ovarian cancer cells, and thereby enhancing its DDP sensitivity.

Source: Cancer Chemotherapy and Pharmacology - January 3, 2021 Category: Cancer & Oncology Source Type: research